Affordable Access

Access to the full text

Effects of neural stem cell transplantation in Alzheimer’s disease models

Authors
  • Hayashi, Yoshihito1, 1
  • Lin, Huan-Ting2
  • Lee, Cheng-Che1
  • Tsai, Kuen-Jer1, 1, 1
  • 1 National Cheng Kung University, Tainan, Taiwan , Tainan (Taiwan)
  • 2 The Institute of Medical Science, The University of Tokyo, Tokyo, Japan , Tokyo (Japan)
Type
Published Article
Journal
Journal of Biomedical Science
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Jan 27, 2020
Volume
27
Issue
1
Identifiers
DOI: 10.1186/s12929-020-0622-x
Source
Springer Nature
Keywords
License
Green

Abstract

Currently there are no therapies for treating Alzheimer’s disease (AD) that can effectively halt disease progression. Existing drugs such as acetylcholinesterase inhibitors or NMDA receptor antagonists offers only symptomatic benefit. More recently, transplantation of neural stem cells (NSCs) to treat neurodegenerative diseases, including AD, has been investigated as a new therapeutic approach. Transplanted cells have the potential to replace damaged neural circuitry and secrete neurotrophic factors to counter symptomatic deterioration or to alter lesion protein levels. However, since there are animal models that can recapitulate AD in its entirety, it is challenging to precisely characterize the positive effects of transplanting NSCs. In the present review, we discuss the types of mouse modeling system that are available and the effect in each model after human-derived NSC (hNSC) or murine-derived NSC (mNSC) transplantation. Taken together, results from studies involving NSC transplantation in AD models indicate that this strategy could serve as a new therapeutic approach.

Report this publication

Statistics

Seen <100 times